Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
Martin Reck1, Keith M Kerr2, Christian Grohé3
1Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
Patients with aggressive non-small-cell lung cancer (NSCLC) may benefit from specific therapies. Aggressive nonsquamous NSCLC is defined by progression within 6-9 months of initial treatment.
Area of Science:
- Oncology
- Medical Oncology
- Thoracic Oncology
Background:
- A significant subset of non-small-cell lung cancer (NSCLC) patients exhibit aggressive disease, characterized by rapid progression or poor response to initial chemotherapy.
- Clinical indicators of aggressive disease during first-line therapy have emerged as predictors of treatment response in specific NSCLC subtypes.
Purpose of the Study:
- To review clinical data and propose a definition for aggressive nonsquamous NSCLC.
- To guide treatment decisions for patients with advanced NSCLC based on disease behavior.
Main Methods:
- Review of clinical data and literature on NSCLC treatment outcomes.
- Analysis of progression patterns in patients receiving first-line platinum-based chemotherapy.
Main Results:
- Aggressive disease features predict enhanced benefit from anti-angiogenic agents like nintedanib, ramucirumab, and bevacizumab in certain NSCLC contexts.
- These features may negatively influence outcomes with nivolumab in nonsquamous NSCLC with low PD-L1 expression.
Conclusions:
- A consensus definition for aggressive nonsquamous NSCLC is proposed: progression within 6-9 months of initiating first-line treatment.
- This definition aims to refine patient stratification for targeted therapies and improve treatment efficacy in NSCLC.
Related Concept Videos
Aggression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Lung Capacity
Overview Of Cell Separation And Isolation
Drug Abuse and Addiction: Pharmacological Phenomena
Defining Psychology

